Cholinergic insufficiency is linked to Alzheimer's disease, and several cholinesterase inhibitors have been created to treat it, including naturally produced inhibitors, synthetic analogs, and hybrids. Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.